New Results
A novel HER2-targeted antibody-drug conjugate offers the possibility of clinical dosing at trastuzumab-equivalent exposure levels
View ORCID ProfileRobyn M. Barfield, Yun Cheol Kim, Stepan Chuprakov, Fangjiu Zhang, Maxine Bauzon, Ayodele O. Ogunkoya, Dominick Yeo, Colin Hickle, Mark D. Pegram, David Rabuka, View ORCID ProfilePenelope M. Drake
doi: https://doi.org/10.1101/2020.03.13.991448
Robyn M. Barfield
1Catalent Biologics, 5959 Horton Street, Ste. 400, Emeryville, CA 94608, USA
Yun Cheol Kim
1Catalent Biologics, 5959 Horton Street, Ste. 400, Emeryville, CA 94608, USA
Stepan Chuprakov
1Catalent Biologics, 5959 Horton Street, Ste. 400, Emeryville, CA 94608, USA
Fangjiu Zhang
1Catalent Biologics, 5959 Horton Street, Ste. 400, Emeryville, CA 94608, USA
Maxine Bauzon
1Catalent Biologics, 5959 Horton Street, Ste. 400, Emeryville, CA 94608, USA
Ayodele O. Ogunkoya
1Catalent Biologics, 5959 Horton Street, Ste. 400, Emeryville, CA 94608, USA
Dominick Yeo
1Catalent Biologics, 5959 Horton Street, Ste. 400, Emeryville, CA 94608, USA
Colin Hickle
1Catalent Biologics, 5959 Horton Street, Ste. 400, Emeryville, CA 94608, USA
Mark D. Pegram
2Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA 94305, USA
David Rabuka
1Catalent Biologics, 5959 Horton Street, Ste. 400, Emeryville, CA 94608, USA
Penelope M. Drake
1Catalent Biologics, 5959 Horton Street, Ste. 400, Emeryville, CA 94608, USA

- Supp. Tables S1-S3 and Supp. Figures S1-S8[supplements/991448_file02.pdf]
Posted March 15, 2020.
A novel HER2-targeted antibody-drug conjugate offers the possibility of clinical dosing at trastuzumab-equivalent exposure levels
Robyn M. Barfield, Yun Cheol Kim, Stepan Chuprakov, Fangjiu Zhang, Maxine Bauzon, Ayodele O. Ogunkoya, Dominick Yeo, Colin Hickle, Mark D. Pegram, David Rabuka, Penelope M. Drake
bioRxiv 2020.03.13.991448; doi: https://doi.org/10.1101/2020.03.13.991448
A novel HER2-targeted antibody-drug conjugate offers the possibility of clinical dosing at trastuzumab-equivalent exposure levels
Robyn M. Barfield, Yun Cheol Kim, Stepan Chuprakov, Fangjiu Zhang, Maxine Bauzon, Ayodele O. Ogunkoya, Dominick Yeo, Colin Hickle, Mark D. Pegram, David Rabuka, Penelope M. Drake
bioRxiv 2020.03.13.991448; doi: https://doi.org/10.1101/2020.03.13.991448
Subject Area
Subject Areas
- Biochemistry (13864)
- Bioengineering (10567)
- Bioinformatics (33580)
- Biophysics (17308)
- Cancer Biology (14374)
- Cell Biology (20351)
- Clinical Trials (138)
- Developmental Biology (10969)
- Ecology (16198)
- Epidemiology (2067)
- Evolutionary Biology (20508)
- Genetics (13509)
- Genomics (18801)
- Immunology (13932)
- Microbiology (32465)
- Molecular Biology (13523)
- Neuroscience (70791)
- Paleontology (532)
- Pathology (2222)
- Pharmacology and Toxicology (3778)
- Physiology (5957)
- Plant Biology (12145)
- Synthetic Biology (3401)
- Systems Biology (8234)
- Zoology (1868)